Jump to main content
eTG Complete
Index
Search
Home
Addiction
Volatile inhalants: hazardous, harmful and dependent use
Addiction
What is covered in the Addiction guidelines?
Overview of substance use and addictive behaviours
Tobacco smoking and nicotine dependence
Alcohol: hazardous, harmful and dependent use
Opioids: hazardous, harmful and dependent use
Benzodiazepines, zolpidem and zopiclone: hazardous, harmful and dependent use
Cannabis: hazardous, harmful and dependent use
Gamma-hydroxybutyrate (GHB): hazardous, harmful and dependent use
Hallucinogens: hazardous and harmful use
Ketamine: hazardous and harmful use
Pregabalin and gabapentin: hazardous, harmful and dependent use
Quetiapine and other antipsychotics: hazardous, harmful and dependent use
Sedating antihistamines: hazardous, harmful and dependent use
Stimulants: hazardous, harmful and dependent use
Volatile inhalants: hazardous, harmful and dependent use
Overview of disorders of volatile inhalant use
Screening and assessment of volatile inhalant use
Overview of management of disorders of volatile inhalant use
Harm reduction in volatile inhalant use
Withdrawal management in disorders of volatile inhalant use
Long-term care in the management of disorders of volatile inhalant use
Further educational resources for healthcare professionals about volatile inhalant use
References
Addictive behaviours
Key resources for substance use and addictive behaviours
Volatile inhalants: hazardous, harmful and dependent use
Published
June 2023
(Amended December 2024)
Overview of disorders of volatile inhalant use
Screening and assessment of volatile inhalant use
Overview of management of disorders of volatile inhalant use
Harm reduction in volatile inhalant use
Withdrawal management in disorders of volatile inhalant use
Long-term care in the management of disorders of volatile inhalant use
Further educational resources for healthcare professionals about volatile inhalant use
